Wall St. rises amid robust GDP data, mixed earnings
Reuters
Published Oct 28, 2016 11:30AM ET
Wall St. rises amid robust GDP data, mixed earnings
By Yashaswini Swamynathan
(Reuters) - Wall Street rose on Friday as robust economic data shone light on the strength of the U.S. economy, while upbeat results from Alphabet and Chevron offset the decline in health stocks and Amazon.
Data showed the U.S. economy grew at its fastest pace in two years. Gross domestic product increased at a 2.9 percent annual rate in the third quarter, helped by a surge in exports, the first estimate by the U.S. Commerce Department revealed.
While the report supports the case for an interest rate hike, the Federal Reserve is highly unlikely to make a move at its meeting next week, as it falls just days ahead of the U.S. presidential election.
However, the odds of a rate increase in December stand at 78.5 percent, according to the CME Group's FedWatch tool.
The main focus of the market remains on corporate results as investors hope the latest quarter snaps a year-long earnings recession.
With an increasing number of S&P 500 companies beating profit estimates, analysts see a 3 percent growth in earnings in the third quarter, according to Thomson Reuters I/B/E/S.
Alphabet's (O:GOOGL) 2.5 percent rise and Chevron's (N:CVX) 3.7 percent jump on upbeat earnings buoyed sentiment. The stocks gave the biggest boost to the S&P 500.
Amazon.com (O:AMZN) was set for its worst day in nearly nine months, falling 4.2 percent to $784.88 after the online retailer warned heavy investments in the crucial holiday quarter would drag profits. The stock was the top drag on the S&P and the Nasdaq.
"(Today's movement) is a tug-of-war among many things," said Brad McMillan, chief investment officer at Commonwealth Financial Network. "It's the certainty that earnings are improving versus the ongoing uncertainty from the election and the Fed."
At 11:02 a.m. ET, the Dow Jones industrial average (DJI) was up 56.94 points, or 0.31 percent, at 18,226.62, the S&P 500 (SPX) was up 5.93 points, or 0.28 percent, at 2,138.97 and the Nasdaq Composite (IXIC) was up 9.78 points, or 0.19 percent, at 5,225.76.
Ten of the 11 major S&P sectors were higher, while healthcare sector (SPXHC) was down 1.4 percent. Amgen (O:AMGN) plunged 9.2 percent to $145.74 after the world's largest biotechnology company reported sales for its flagship drug that disappointed investors and analysts.
Mastercard (N:MA) touched a record high of $107.50 after the world's second-biggest payments processor reported a 21.2 percent jump in quarterly profit. The results also lifted shares of larger rival Visa (N:V). Advancing issues outnumbered decliners on the NYSE by 1,666 to 1,093. On the Nasdaq, 1,421 issues rose and 1,118 fell.
Get The News You Want
The S&P 500 index showed eight new 52-week highs and nine new lows, while the Nasdaq recorded 32 new highs and 87 new lows.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.